Haemodynamic Effects of Acebutolol

Overview

Journal Br Heart J

Specialty Cardiology & Vascular Diseases

Date 1978 Jan 1

PMID 341929

Citations 3

Authors

J W Mason

M J Specter

N B Ingels

G T Daughters

A C Ferris

E L Alderman

Affiliations

Soon will be listed here.

Citing Articles

Acute effects of acebutolol on cardiovascular function in man.

Dalal J, Ross P, Wong K, Sheridan D, Ruttley M, Lewis M Br J Clin Pharmacol. 1981; 11(3):265-8.

PMID: 7213527 PMC: 1401624. DOI: 10.1111/j.1365-2125.1981.tb00532.x.

How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.

Man in t Veld A, SCHALEKAMP M Br J Clin Pharmacol. 1982; 13(Suppl 2):245S-257S.

PMID: 6125175 PMC: 1402134. DOI: 10.1111/j.1365-2125.1982.tb01922.x.

Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.

Singh B, Thoden W, Ward A Drugs. 1985; 29(6):531-69.

PMID: 3891306 DOI: 10.2165/00003495-198529060-00003.

References

Meffin P, Harapat S, Harrison D . Quantitation in plasma and urine of acebutolol and a major metabolite with preliminary observations on their disposition kinetics in man. Res Commun Chem Pathol Pharmacol. 1976; 15(1):31-51. View

Eckberg D, Drabinsky M, Braunwald E . Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med. 1971; 285(16):877-83. DOI: 10.1056/NEJM197110142851602. View

Kumana C, Kaye C, Leighton M, Turner P, Hamer J . Cardiac and pulmonary effects of acebutolol. Lancet. 1975; 2(7925):89-93. DOI: 10.1016/s0140-6736(75)90001-x. View

Lewis B, Bakst A, Mitha A, Purdon K, Gotsman M . Haemodynamic effects of a new beta-blocking agent 'Sectral' (M & B 17803A). Br Heart J. 1973; 35(7):743-51. PMC: 458693. DOI: 10.1136/hrt.35.7.743. View

Lewis B, Bakst A, Kitchiner D, Gotsman M . Sectral in the management of angina pectoris. S Afr Med J. 1973; 47(32):1455-9. View